Cargando…
Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671907/ https://www.ncbi.nlm.nih.gov/pubmed/36396645 http://dx.doi.org/10.1038/s41467-022-34545-6 |
_version_ | 1784832641532428288 |
---|---|
author | Zhang, Peitao Guan, Haixia Yuan, Shukai Cheng, Huili Zheng, Jian Zhang, Zhenlei Liu, Yifan Yu, Yang Meng, Zhaowei Zheng, Xiangqian Zhao, Li |
author_facet | Zhang, Peitao Guan, Haixia Yuan, Shukai Cheng, Huili Zheng, Jian Zhang, Zhenlei Liu, Yifan Yu, Yang Meng, Zhaowei Zheng, Xiangqian Zhao, Li |
author_sort | Zhang, Peitao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9671907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96719072022-11-19 Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors Zhang, Peitao Guan, Haixia Yuan, Shukai Cheng, Huili Zheng, Jian Zhang, Zhenlei Liu, Yifan Yu, Yang Meng, Zhaowei Zheng, Xiangqian Zhao, Li Nat Commun Author Correction Nature Publishing Group UK 2022-11-17 /pmc/articles/PMC9671907/ /pubmed/36396645 http://dx.doi.org/10.1038/s41467-022-34545-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Zhang, Peitao Guan, Haixia Yuan, Shukai Cheng, Huili Zheng, Jian Zhang, Zhenlei Liu, Yifan Yu, Yang Meng, Zhaowei Zheng, Xiangqian Zhao, Li Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title | Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title_full | Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title_fullStr | Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title_full_unstemmed | Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title_short | Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors |
title_sort | author correction: targeting myeloid derived suppressor cells reverts immune suppression and sensitizes braf-mutant papillary thyroid cancer to mapk inhibitors |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671907/ https://www.ncbi.nlm.nih.gov/pubmed/36396645 http://dx.doi.org/10.1038/s41467-022-34545-6 |
work_keys_str_mv | AT zhangpeitao authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT guanhaixia authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT yuanshukai authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT chenghuili authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT zhengjian authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT zhangzhenlei authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT liuyifan authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT yuyang authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT mengzhaowei authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT zhengxiangqian authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors AT zhaoli authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors |